H.R.2062 - Overdose Prevention and Patient Safety Act116th Congress (2019-2020)
|Sponsor:||Rep. Blumenauer, Earl [D-OR-3] (Introduced 04/03/2019)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 04/04/2019 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.2062 — 116th Congress (2019-2020)All Information (Except Text)
Introduced in House (04/03/2019)
Overdose Prevention and Patient Safety Act
This bill more closely aligns the federal privacy standards for substance use disorder (SUD) patient records with the standards under the Health Insurance Portability and Accountability Act (HIPAA). Specifically, the bill authorizes the disclosure of SUD patient records without a patient's written consent to: (1) a covered entity for the purposes of treatment, payment, and health care operations, as long as the disclosure is made in accordance with HIPAA; and (2) a public health authority, as long as the content of the disclosure meets HIPAA standards regarding de-identified information. Current law authorizes disclosure of SUD patient records without a patient's written consent only to medical personnel in a medical emergency, to specified personnel for research or program evaluations, or pursuant to a court order.
The bill also repeals and replaces criminal penalties for certain violations involving SUD patient records with the HIPAA civil penalty structure. It also applies HIPAA criminal penalties to wrongful disclosures of SUD patient records. In addition, the bill expands the current prohibition against using SUD patient records in criminal proceedings to include any use in specified federal, state, and local criminal and civil actions.
The bill prohibits certain discrimination based on the release of SUD information under this bill.